Evidence map›Paper›PMID 29654210›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2018

c-Myb Coordinates Survival and the Expression of Genes That Are Critical for the Pre-BCR Checkpoint.

Shawn P Fahl, Andrea R Daamen, Rowena B Crittenden, Timothy P Bender

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Shawn P FahlDepartment of Microbiology, Immunology and Cancer Biology, University of Virginia Health System, Charlottesville, VA 22908; and.
Andrea R DaamenDepartment of Microbiology, Immunology and Cancer Biology, University of Virginia Health System, Charlottesville, VA 22908; and.
Rowena B CrittendenDepartment of Microbiology, Immunology and Cancer Biology, University of Virginia Health System, Charlottesville, VA 22908; and.
Timothy P BenderDepartment of Microbiology, Immunology and Cancer Biology, University of Virginia Health System, Charlottesville, VA 22908; and tpb3e@virginia.edu.
University of Virginia Health System · USCarter Center · US

Funding

INTERDISCIPLINARY TRAINING PROGRAM IN IMMUNOLOGYT32AI007496 · NIAID · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Michael G. Brown, Coleen A McNamara · 1995 to 2026
$10.2M
c-myb in B Cell Development and FunctionR01AI059294 · NIAID · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI BENDER, TIMOTHY P. · 2005 to 2009
$1.8M
c-Myb controls survival, proliferation and differentiation during B-lymphopoiesisR01GM100776 · NIGMS · UNIVERSITY OF VIRGINIA · PI BENDER, TIMOTHY P. · 2011 to 2014
$1.1M
NIAID NIH HHS R01 AI059294NIAID NIH HHS T32 AI007496NIGMS NIH HHS R01 GM100776
6 · The paper itself

Abstract

The c-Myb transcription factor is required for adult hematopoiesis, yet little is known about c-Myb function during lineage-specific differentiation due to the embryonic lethality of

Indexed as

AnimalsAntigens, CD19Cell DifferentiationCell ProliferationCyclin D3MicePrecursor Cells, B-LymphoidProto-Oncogene Proteins c-mybReceptors, CXCR4Receptors, Interleukin-7Signal TransductionSTAT5 Transcription FactorSuppressor of Cytokine Signaling 3 ProteinAntigens, CD19Cyclin D3interleukin-7 receptor, alpha chainProto-Oncogene Proteins c-mybReceptors, CXCR4Receptors, Interleukin-7STAT5 Transcription FactorSuppressor of Cytokine Signaling 3 Protein

Identifiers

PMID29654210
PMCPMC5940554
OpenAlexW2797199607

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.